Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer

16h ago

ATOS

PremiumPress Releases

Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

5d ago

ATOS

PremiumPress Releases

Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen

7d ago

ATOS

PremiumThe Fly

Atossa Therapeutics presents data from 40mg cohort of Phase 2 EVANGELINE trial

7d ago

ATOS

PremiumCompany Announcements

Navigating Choppy Waters: Atossa Therapeutics’ Struggle with Compliance Costs and Business Performance

13d ago

ATOS

PremiumPress Releases

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

14d ago

ATOS

PremiumPre-Earnings

Is ATOS a Buy, Before Earnings?

21d ago

ATOS

More ATOS News >

ATOS News on the Web

2024-04-11

Atossa (ATOS) Reports Positive Results From EVANGELINE Study

Zacks

Neutral

2024-04-11

Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

Yahoo Finance

Neutral

2024-04-10

Atossa Therapeutics Poised for Growth with Promising Breast Cancer Treatment

TipRanks News

Bullish

2024-04-09

Atossa Therapeutics reports positive data from breast cancer treatment trial

Proactive Investors

Neutral

2024-04-09

Atossa Therapeutics reports positive data from breast cancer treatment trial

Proactive Investors

Neutral

2024-04-09

Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with -Endoxifen

Yahoo Finance

Neutral

2024-04-06

MicroMarvel - Atossa Therapeutics

TalkMarkets

Bullish

2024-04-03

Analysts Are Bullish on These Healthcare Stocks: Atossa Therapeutics (ATOS), Arbutus Biopharma (ABUS)

TipRanks News

Bullish

News Score - Last 7 Days

Neutral

ATOS

Sector Average

Media Buzz

This Week6 articles

Weekly Average6.25 articles

News Sentiment

This Week100%

Sector Average66%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATOS’s Media Buzz Sentiment?

6 articles about ATOS were published this week. In an average week, 6.25 articles are published.

What is ATOS’s weekly average amount of articles?

In an average week, 6.25 articles about ATOS are published.

What is ATOS’s News Sentiment?

100% of articles about ATOS were positive this week, compared to its sector average of 66%.

Healthcare Stocks that are Trending in the News

ANSLFAnsell

JANXJanux Therapeutics Inc

PTNPalatin Technologies

LEGNLegend Biotech

0HNZFagron SA

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing